Literature DB >> 2160411

Metabolic activation of natural phenols into selective oxidative burst agonists by activated human neutrophils.

J M Simons1, B A Hart, T R Ip Vai Ching, H Van Dijk, R P Labadie.   

Abstract

Phenols isolated from the traditional medicinal plant Picrorhiza kurroa inhibit the release of superoxide anion (O2-) by activated human neutrophils, but leave the phagocytotic capacity intact. Resting neutrophils and resting or activated human lymphocytes are insensitive to these agents. The underlying mechanism of this highly selective activity is investigated. A critical event is the reaction of the phenols with secretory products from the activated neutrophils. The reaction products interfere with the assembly of a functional NADPH-oxidase in the membrane. Analysis of the mode of activation of the phenols reveals two possible pathways. Catechols react directly with reactive oxygen species (ROS) from the oxidative burst. For the activation of the orthomethoxy-substituted catechols the combined activity of ROS and myeloperoxidase (MPO) is obligatory. Catechols with a dimethoxy substitution cannot be activated metabolically by neutrophil-derived ROS.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2160411     DOI: 10.1016/0891-5849(90)90070-y

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  59 in total

1.  Distinct role for microglia in rotenone-induced degeneration of dopaminergic neurons.

Authors:  Hui-Ming Gao; Jau-Shyong Hong; Wanqin Zhang; Bin Liu
Journal:  J Neurosci       Date:  2002-02-01       Impact factor: 6.167

Review 2.  NADPH oxidase in stroke and cerebrovascular disease.

Authors:  Xian Nan Tang; Belinda Cairns; Jong Youl Kim; Midori A Yenari
Journal:  Neurol Res       Date:  2012-05       Impact factor: 2.448

Review 3.  Immunomodulation by quinones. A model for the use of quinones in the treatment of inflammation.

Authors:  L A 'T Hart
Journal:  Pharm Weekbl Sci       Date:  1991-06-21

4.  Diapocynin and apocynin administration fails to significantly extend survival in G93A SOD1 ALS mice.

Authors:  Kari A Trumbull; Donna McAllister; Mandi M Gandelman; Whitney Y Fung; Thomas Lew; Lucy Brennan; Nathan Lopez; Jeff Morré; Balaraman Kalyanaraman; Joseph S Beckman
Journal:  Neurobiol Dis       Date:  2011-07-28       Impact factor: 5.996

5.  An Effective NADPH Oxidase 2 Inhibitor Provides Neuroprotection and Improves Functional Outcomes in Animal Model of Traumatic Brain Injury.

Authors:  Mengwei Wang; Le Luo
Journal:  Neurochem Res       Date:  2020-02-18       Impact factor: 3.996

6.  Increased oxidative stress in obesity and its impact on metabolic syndrome.

Authors:  Shigetada Furukawa; Takuya Fujita; Michio Shimabukuro; Masanori Iwaki; Yukio Yamada; Yoshimitsu Nakajima; Osamu Nakayama; Makoto Makishima; Morihiro Matsuda; Iichiro Shimomura
Journal:  J Clin Invest       Date:  2004-12       Impact factor: 14.808

7.  Reduction of cerebral infarct volume by apocynin requires pretreatment and is absent in Nox2-deficient mice.

Authors:  K A Jackman; A A Miller; T M De Silva; P J Crack; G R Drummond; C G Sobey
Journal:  Br J Pharmacol       Date:  2009-01-23       Impact factor: 8.739

8.  Aldosterone increases oxidant stress to impair guanylyl cyclase activity by cysteinyl thiol oxidation in vascular smooth muscle cells.

Authors:  Bradley A Maron; Ying-Yi Zhang; Diane E Handy; Annie Beuve; Shiow-Shih Tang; Joseph Loscalzo; Jane A Leopold
Journal:  J Biol Chem       Date:  2009-01-13       Impact factor: 5.157

9.  Role of superoxide anions in airway hyperresponsiveness induced by cigarette smoke in conscious guinea pigs.

Authors:  M Nishikawa; M Kudo; N Kakemizu; H Ikeda; T Okubo
Journal:  Lung       Date:  1996       Impact factor: 2.584

10.  Androgens induce oxidative stress and radiation resistance in prostate cancer cells though NADPH oxidase.

Authors:  J P Lu; L Monardo; I Bryskin; Z F Hou; J Trachtenberg; B C Wilson; J H Pinthus
Journal:  Prostate Cancer Prostatic Dis       Date:  2009-06-23       Impact factor: 5.554

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.